7 Red Flags in GLP-1 Telehealth: What to Watch For Before Signing Up

The GLP-1 telehealth market is booming — and wherever there's demand and money, there are operators cutting corners. Not every red flag means a platform is dangerous, but some should make you pause, investigate, or walk away entirely.

Red Flag #1: Guaranteed Prescriptions

Any platform that promises "you will receive a prescription" before evaluating your medical history is violating basic medical ethics and potentially breaking the law. A legitimate prescriber cannot guarantee a prescription outcome before conducting a clinical evaluation. If a platform's marketing guarantees results, it means their "evaluation" is a rubber stamp — not a medical assessment.

Red Flag #2: No Identifiable Prescribers

If a platform won't tell you who's writing your prescription — or if the prescriber's credentials can't be verified through your state medical board — that's a serious concern. Every prescription should be written by a named, verifiable, state-licensed provider. "Our team of medical professionals" with no names or credentials is not sufficient.

Red Flag #3: Claiming Compounded Drugs Are FDA-Approved

Compounded GLP-1 medications are not FDA-approved. Period. Any platform that describes compounded semaglutide or tirzepatide as "FDA-approved," "equivalent to Wegovy/Ozempic," or uses branding that implies FDA endorsement is violating federal law. This is the exact issue that triggered 80+ FDA warning letters in 2025–2026.

Red Flag #4: No Follow-Up Care

GLP-1 therapy requires ongoing medical management — dose titration, side-effect monitoring, and treatment adjustments. A platform that prescribes and then disappears isn't providing medical care; it's selling medication. Ask: How often will I see a provider? Can I message my care team between visits? What happens if I experience severe side effects?

Red Flag #5: Suspicious Pricing

Compounded semaglutide from a legitimate U.S. pharmacy typically costs $100–350 per month depending on dose and provider. If a platform offers "real semaglutide" for $50/month or less, question the source. Extremely low prices may indicate overseas sourcing, diluted formulations, or products that don't contain the labeled active ingredient.

On the other end, prices above $500/month for compounded products should prompt scrutiny too — you may be paying a significant markup over the cost of compounding.

Red Flag #6: No Compounding Pharmacy Transparency

You should be able to answer the question: "Where is my medication made?" If the platform won't identify its compounding pharmacy partner, you can't verify the pharmacy's license, accreditation, or regulatory standing. PCAB-accredited pharmacies (about 8% of all compounding pharmacies) have undergone independent quality assessment. 503B outsourcing facilities are FDA-registered.

Red Flag #7: Pressure to Start Immediately

Urgency tactics — countdown timers, "limited supply" messaging, "act now or lose your spot" — are marketing strategies, not medical advice. Legitimate platforms don't pressure you to start treatment before you're ready. If a platform creates artificial urgency, it's prioritizing conversions over patient care.

How to Verify Any Platform

Before signing up, spend 10 minutes verifying: Check LegitScript.com for the platform's verification status. Search the FDA's warning letter database for the platform's name. Look up the prescribing provider through your state medical board. Verify the compounding pharmacy through your state Board of Pharmacy. Read the terms of service for cancellation policies and commitment requirements.

If a platform passes all these checks, you can proceed with reasonable confidence. If it fails any of them, keep looking.